| Original language | English (US) |
|---|---|
| Pages (from-to) | 1058-1061 |
| Number of pages | 4 |
| Journal | British Journal of Haematology |
| Volume | 184 |
| Issue number | 6 |
| DOIs | |
| State | Published - Mar 2019 |
Keywords
- Prasugrel
- children
- multinational
- pain
- sickle cell anaemia
ASJC Scopus subject areas
- Hematology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia. / Kanter, Julie; Heath, Lori E.; Knorr, Jack et al.
In: British Journal of Haematology, Vol. 184, No. 6, 03.2019, p. 1058-1061.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia
AU - Kanter, Julie
AU - Heath, Lori E.
AU - Knorr, Jack
AU - Agbenyega, E. Tsiri
AU - Colombatti, Raffaella
AU - Dampier, Carlton
AU - Hassab, Hoda
AU - Manwani, Deepa
AU - Robitaille, Nancy
AU - Brown, Patricia B.
AU - Jakubowski, Joseph A.
AU - Yao, Suqin
AU - Hoppe, Carolyn
N1 - Funding Information: LE Heath, J Knorr, PB Brown, JA Jakubowski, and S Yao are employees or former employees of Eli Lilly and Company. J Kanter and CC Hoppe have received research support for performance of clinical trials from Eli Lilly, and Selexys Pharmaceuticals, and consulting fees from Global Blood Therapeutics, and Cydan. C Dampier has received consulting fees from Pfizer, Eli Lilly and Company, Baxter, Biogen Idec, and GlycoMimetics and grant support for performance of clinical trials from Pfizer, AstraZeneca, Eli Lilly and Company, and the National Institutes of Health. Funding Information: This study was sponsored by Daiichi-Sankyo Company, Ltd and Eli Lilly and Company. Medical writing assistance was provided by Gayle Scott, PharmD, CMPP of ProScribe ? Envision Pharma Group, and was funded by Eli Lilly and Company. ProScribe's services complied with international guidelines for Good Publication Practice (GPP3). Eli Lilly and Company was involved in the study design, data collection, data analysis and preparation of the manuscript. Funding Information: This study was sponsored by Daiichi-Sankyo Company, Ltd and Eli Lilly and Company. Medical writing assistance was provided by Gayle Scott, PharmD, CMPP of ProScribe – Envision Pharma Group, and was funded by Eli Lilly and Company. ProScribe’s services complied with international guidelines for Good Publication Practice (GPP3). Eli Lilly and Company was involved in the study design, data collection, data analysis and preparation of the manuscript.
PY - 2019/3
Y1 - 2019/3
KW - Prasugrel
KW - children
KW - multinational
KW - pain
KW - sickle cell anaemia
UR - http://www.scopus.com/inward/record.url?scp=85060545350&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060545350&partnerID=8YFLogxK
U2 - 10.1111/bjh.15250
DO - 10.1111/bjh.15250
M3 - Letter
C2 - 29676449
AN - SCOPUS:85060545350
SN - 0007-1048
VL - 184
SP - 1058
EP - 1061
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 6
ER -